Ensign Peak Advisors
AGN

Ensign Peak Advisors’s Allergan plc AGN Stock Holding History

Ensign Peak Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-21,575
Closed -$3.82M – 1713
2020
Q1 		$3.82M Sell
21,575
-19,805
-48% -$3.73M 0.01% 590
2019
Q4 		$7.91M Buy
+41,380
New +$7.46M 0.02% 513

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Ensign Peak Advisors's AGN Position: Q2 2020 in Review

Ensign Peak Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 21,575 shares — an estimated $3.82M sold.

Ensign Peak Advisors first reported a position in AGN in Q4 2019 and held it in 2 quarters. The position peaked at $7.91M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Ensign Peak Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Ensign Peak Advisors sold 21,575 Allergan plc shares in Q2 2020, an estimated $3.82M.
  • Ensign Peak Advisors first reported a position in Allergan plc in Q4 2019 and held it in 2 quarters.
  • Ensign Peak Advisors's Allergan plc position peaked at $7.91M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Ensign Peak Advisors's 13F filing for Q2 2020, filed 12 Aug 2020.